JCI - Citations to Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.

Citations to this article

Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity.

L I Brasoveanu, … , M Altomonte, M Maio

L I Brasoveanu, … , M Altomonte, M Maio

Published September 1, 1997
Citation Information: J Clin Invest. 1997;100(5):1248-1255. https://doi.org/10.1172/JCI119638.

View: Text | PDF

Research Article

Total citations by year

Year:	2020	2019	2018	2017	2016	2014	2013	2012	2006	2004	2003	2002	2001	1999	1992	1981	Total
Citations:	1	2	1	1	3	1	1	1	1	2	1	2	4	3	1	1	26

Citation information

Citations to this article (26)

Title and authors	Publication	Year
Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function B Faria, MG da Costa, C Lima, L Willems, R Brandwijk, SP Berger, MR Daha, M Pestana, MA Seelen, F Poppelaars	Journal of Nephrology	2020
Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention Z Fishelson, M Kirschfink	Frontiers in immunology	2019
Identification of one novel pathogenic ITGB3 mutation and two known mutations in two Chinese pedigrees with hereditary Glanzmann thrombasthenia Z Lu, L Nikuze, Z Zhong, F Li, F Zhang, K Liang, M Wei, H Wei	Platelets	2019
The release of glycosylphosphatidylinositol-anchored proteins from the cell surface GA Müller	Archives of Biochemistry and Biophysics	2018
Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes Z Wang, W Guo, Y Liu, Y Gong, X Ding, K Shi, R Thome, GX Zhang, FD Shi, Y Yan	Brain, Behavior, and Immunity	2017
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies TM Shaver, BD Lehmann, JS Beeler, CI Li, Z Li, H Jin, TP Stricker, Y Shyr, JA Pietenpol	Cancer research	2016
Immune Protection of Retroviral Vectors Upon Molecular Painting with the Complement Regulatory Protein CD59 S Heider, S Kleinberger, F Kochan, JA Dangerfield, C Metzner	Molecular Biotechnology	2016
Drug Discovery and Evaluation: Pharmacological Assays FJ Hock		2016
Advances in Experimental Medicine and Biology R Pio, L Corrales, JD Lambris	Advances in experimental medicine and biology	2014
Construction and characterization of recombinant human C9 or C7 linked to single Chain Fv directed to CD25 MR Gurevich, Z Fishelson	Molecular Immunology	2013
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases G Müller	Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy	2012
Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins G Lauc, M Heffer-Lauc	Biochimica et Biophysica Acta (BBA) - General Subjects	2006
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy? E Fonsatti, AM di Giacomo, M Maio	Journal of Translational Medicine	2004
Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer NK Rushmere, JM Knowlden, JM Gee, ME Harper, JF Robertson, BP Morgan, RI Nicholson	International Journal of Cancer	2004
Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid N Donin, K Jurianz, L Ziporen, S Schultz, M Kirschfink, Z Fishelson	Clinical & Experimental Immunology	2003
Expression of complement regulating factors in gastric cancer cells T Inoue, M Yamakawa, T Takahashi	Molecular pathology : MP	2002
European approach to antibody-based immunotherapy of melanoma M Altomonte, M Maio	Seminars in Oncology	2002
K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement K Jurianz, S Ziegler, N Donin, Y Reiter, Z Fishelson, M Kirschfink	International Journal of Cancer	2001
A Novel Secreted Tumor Antigen with a Glycosylphosphatidylinositol-Anchored Structure Ubiquitously Expressed in Human Cancers H Onda, S Ohkubo, Y Shintani, K Ogi, K Kikuchi, H Tanaka, K Yamamoto, I Tsuji, Y Ishibashi, T Yamada, C Kitada, N Suzuki, H Sawada, O Nishimura, M Fujino	Biochemical and Biophysical Research Communications	2001
Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells*: TRANSMEMBRANE CD59 IN MELANOMA CELLS CD Nardo, E Fonsatti, L Sigalotti, L Calabrò, F Colizzi, E Cortini, S Coral, M Altomonte, M Maio	Journal of Cellular Physiology	2001
Endoglin: An accessory component of the TGF-?-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies E Fonsatti, LD Vecchio, M Altomonte, L Sigalotti, MR Nicotra, S Coral, PG Natali, M Maio	Journal of Cellular Physiology	2001
Expression of complement regulator proteins in primary and metastatic malignant melanoma M Weichenthal, U Siemann, K Neuber, EW Breitbart	Journal of Cutaneous Pathology	1999
Complement resistance of tumor cells: basal and induced mechanisms K Jurianz, S Ziegler, H Garcia-Schüler, S Kraus, O Bohana-Kashtan, Z Fishelson, M Kirschfink	Molecular Immunology	1999
Immune evasion of tumor cells using membrane-bound complement regulatory proteins A Gorter, S Meri	Immunology Today	1999
The Complement System A Agostoni, M Cicardi, M Gardinali, L Bergamaschini	International journal of immunopathology and pharmacology	1992
Autoimmunity AJ King, SA Schwartz, DE Lopatin, JJ Voorhees, LA Diaz	International Journal of Dermatology	1981

Advertisement